Informace o projektu
COVID-19 Vaccines Safety Tracking in the Czech Republic
(CoVaST-CZ)
- Kód projektu
- MUNI/IGA/1104/2021
- Období řešení
- 1/2022 - 12/2022
- Investor / Programový rámec / typ projektu
-
Masarykova univerzita
- Interní grantová agentura MU
- Fakulta / Pracoviště MU
- Lékařská fakulta
COVID-19 vaccines are the sole evidence-based intervention to control the ongoing pandemic, thus mandating substantial levels of public confidence in vaccines to accelerate the mass vaccination efforts. This project aims to provide independent post-marketing (phase IV) evidence on the short-term side effects of COVID-19 vaccines among the Czech population, focusing on booster doses, healthcare and pedagogical workers, and the young population.
Publikace
Počet publikací: 14
2022
-
Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees
Frontiers in Public Health, rok: 2022, ročník: 10, vydání: April 2022, DOI
-
Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study
Frontiers in Public Health, rok: 2022, ročník: 10, vydání: July 2022, DOI
-
Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers
Frontiers in Public Health, rok: 2022, ročník: 10, vydání: May 2022, DOI
-
Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA
Vaccines, rok: 2022, ročník: 10, vydání: 12, DOI